- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01284374
Parent-son-provider Decision-making About HPV Vaccination
An Investigation of Parent-son-provider Decision-making About HPV Vaccination
The objectives of this study are:
- To better understand factors associated with acceptance and refusal of HPV vaccine among parent-son pairs and the process of parent-son decision-making with respect to vaccination.
- To evaluate health care providers (HCPs) attitudes, implementation intentions, and planned communication strategies with respect to HPV vaccination of adolescent boys.
Hypothesis 1: Sons will have a significant role in the process of parent-son decision-making about HPV vaccination. The relative importance of this role will increase with the son's age.
Hypothesis 2: Pediatric HCPs will be unsure about vaccinating males and will lack knowledge about issues related to male HPV infection and vaccination.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
This protocol will involve individual semi-structured qualitative interviews with 30 parent-son dyads and 20 pediatric health care providers. Parent-son pairs will be recruited from IUMG primary care adolescent health clinics. Recruitment will occur and consent/assent for participation obtained during the visit with the health care provider, with the physician out of the room. Interviews with parents and sons will take place after the health care appointment and after HPV vaccine acceptance/refusal. Parents and sons will be administered a brief questionnaire that will cover socio-demographic and other background information. The parent-son interviews will be separate, simultaneous one-on-one ethnographic interviews (30-60 min) that focus on the decision making process regarding HPV vaccination (yes/no). Each interview will consist of 8-10 open-ended questions, serving as an elicitation device. Sample questions include: (1) Tell me what you understand about the HPV vaccine? (2) Tell me what happened when you were in the examination room and your doctor asked you and your parent/son about getting the vaccine? (3) Was the decision made quickly, or did you have a conversation about it first? (4) Who had the most influence on the decision, you or your parent/son? (5) Why did you decide to get (or not to get) the vaccine? The interviewer will ask participants to elaborate on the meaning and contexts of their responses, and look for organization in what the participant is saying, developing and testing hypotheses during the interview. Each interview will be conducted by a trained, gender-matched research assistant.
Health care providers will be interviewed at a different time, and the interviews (25-30 min) will focus on HPV vaccine related attitudes, supply, costs, communication and perceived benefits associated with vaccinating adolescent males, rather than care to specific patients. Sample questions include: (1) How do you inform patients about the HPV vaccine? (2) What is the specific wording that you use when you offer HPV vaccine? Be very specific. Don't leave out any detail.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46202
- IU Medical Group Primary Care Clinic (IUMG-PC), including Wishard primary care clinics
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
Adolescent:
- English-speaking adolescent boys
- 13-17 years of age
- No prior receipt of HPV vaccine
- Accompanied by parent
Parent:
- English-speaking or Spanish-speaking parent
Health Care Provider:
- Physician
- Provides care to adolescent boys 13-17 years of age
Exclusion Criteria:
Adolescent:
- Non-English-speaking
- Younger than 13 or older than 17
- Previous receipt of 1 or more doses of HPV vaccine
Parent:
- Non-English-speaking and Non-Spanish-speaking
Health Care Provider:
- Not a physician
- Does not provide care to males 13-17 years of age
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Kohorter og interventioner
Gruppe / kohorte |
---|
Male Adolescents
Male adolescents, 13-17 years old, who are seen at community adolescent health clinics and are offered HPV vaccine
|
Parents of Male Adolescents
Parents of Male Adolescents, whose adolescents are being seen at community adolescent health clinics and are offered HPV vaccine
|
Health Care Providers for Males 13-17 yo
Health care providers who provide medical care to male adolescents in pediatric and adolescent clinics
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Decision Regarding Acceptance/Refusal of 1st Dose of HPV Vaccine
Tidsramme: Up to 1 hour
|
The semi-structured interviews with parents & sons will focus on how the decision was made to accept or refuse HPV vaccine.
The interviews will take place immediately after the clinic visit during which the vaccination decision was made.
|
Up to 1 hour
|
Health care providers decision-making regarding HPV vaccination of males
Tidsramme: Up to 1 hour
|
Semi-structured interviews will be conducted with 20 health care providers regarding their decision-making around vaccinating adolescent male patients against HPV
|
Up to 1 hour
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- Merck IISP 38094
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Human Papillomavirus Vaccination
-
Columbia UniversityNational Cancer Institute (NCI); Makerere UniversityIkke rekrutterer endnuHuman Papillomavirus VaccinationForenede Stater, Uganda
-
Indiana UniversityMerck Sharp & Dohme LLCAfsluttetHuman Papillomavirus VaccinationForenede Stater
-
Plan A Health, IncMerck Sharp & Dohme LLCTilmelding efter invitationHuman Papillomavirus VaccinationForenede Stater
-
Columbia UniversityNational Cancer Institute (NCI); Makerere UniversityAfsluttet
-
International Agency for Research on CancerTilmelding efter invitationHuman Papillomavirus VaccinationFrankrig
-
University of PennsylvaniaAfsluttetVaccine afslag | Vaccinationstøven | Human Papillomavirus VaccinationForenede Stater
-
Xiamen Innovax Biotech Co., LtdAfsluttet
-
London School of Hygiene and Tropical MedicineMerck Sharp & Dohme LLC; Public Health England; University of CambridgeAktiv, ikke rekrutterendeHuman Papillomavirus VaccineGambia
-
Washington University School of MedicineNational Cancer Institute (NCI)Aktiv, ikke rekrutterende
-
Arizona State UniversityNational Institute on Minority Health and Health Disparities (NIMHD); Adelante...Afsluttet